This man in his early 40s, who had no medical history, was referred to the burn clinic 20 days after being burned in a gasoline fire. Twelve days after the injury, he started to develop purulent ...

Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome ...

Reports Q revenue EUR 165,789 vs EUR 63, 089 last year. Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx (IFRX), ...

Mum Teresa Jones, 59, was diagnosed with Pyoderma Gangrenosum - a rare skin condition that causes large, painful ulcers to ...

A MUM begged doctors to amputate her leg after ‘bug bites’ turned out to be a flesh-rotting disease. Teresa Jones told how ...

The 59-year-old was left housebound for a year due to the agonising pain and she had to watch as nurses cut away chunks of ...

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

A 39-year-old father is suffering from a horrifically painful skin disease that doctors can't cure or even definitively ...

Ryan Becker from Spokane is battling a rare medical condition that has left doctors at the Mayo Clinic and Johns Hopkins ...

HC Wainwright restated their buy rating on shares of InflaRx (NASDAQ:IFRX – Free Report) in a report published on Friday morning,Benzinga reports. HC Wainwright currently has a $8.00 price target on ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement ...

Entyvio’s dosage is an intravenous (IV) infusion every 8 weeks or a subcutaneous injection every 2 weeks. The starting dosage is two infusions 2 weeks apart. After that, you’ll continue with ...